A bootstrap test procedure for treatment-biomarker interaction in phase Ⅲ clinical trials

来源 :泛华统计学会(icsa)2015年学术会议 | 被引量 : 0次 | 上传用户:fdsth5x1
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  In clinical trials,patients with different biomarker features may respond differently to the new treatments or drugs.In personalized medicine,it is important to study the interaction between treatment and biomarkers in order to clearly identify patients that benefit from the treatment.
其他文献
Biomarker identification has gained substantial attention recently in developing personalized medicine for cancer patients.In particular,nowadays there are usua
会议
会议
会议
Interval-censored data arise commonly in epidemiological and medical studies where students are measured at different follow-up times.The response of interest i
会议
会议
会议
会议
会议
会议
会议